Provided by Tiger Trade Technology Pte. Ltd.

Progress

40.28
-0.3300-0.81%
Volume:75.93K
Turnover:3.07M
Market Cap:1.65B
PE:19.46
High:41.21
Open:40.63
Low:40.01
Close:40.61
52wk High:47.37
52wk Low:23.82
Shares:41.01M
Float Shares:40.11M
Volume Ratio:0.36
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):1.66
ROE:18.57%
ROA:4.89%
PB:3.26
PE(LYR):24.27

Loading ...

Novartis Needs to Make Progress on Pipeline to Justify Valuation

Dow Jones
·
Yesterday

Foresight Group Updates Market on Progress of Ongoing Share Buyback Programme

TIPRANKS
·
Yesterday

FSA Group Updates Market on Daily Progress of On-Market Share Buy-Back

TIPRANKS
·
Yesterday

Vita Life Sciences Updates Market on Progress of On-Market Share Buy-Back

TIPRANKS
·
Yesterday

Mirrabooka Updates Investors on Progress of On-Market Share Buy-Back

TIPRANKS
·
Yesterday

AFI Reports Daily Progress in On‑Market Share Buy‑Back

TIPRANKS
·
Yesterday

BrainChip to Brief Investors on Q2 2026 Progress and Edge AI Strategy

TIPRANKS
·
Yesterday

Select Harvests Reports Progress on Ongoing On-Market Share Buy-Back

TIPRANKS
·
Yesterday

Flight Centre Updates Investors on Progress of On-Market Share Buy-Back

TIPRANKS
·
Yesterday

Helia Group Updates ASX on Progress of On-Market Share Buy-Back

TIPRANKS
·
Yesterday

Brambles Updates Market on Progress of Ongoing Share Buy-Back

TIPRANKS
·
Yesterday

Perenti Updates ASX on Progress of On-Market Share Buy-Back

TIPRANKS
·
Yesterday

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

TIPRANKS
·
Yesterday

SS Innovations Provides Update on Continuing Progress and Milestones

GlobeNewswire
·
Sep 10

Thomas Shrader Reiterates Buy on IRD, Maintains $12 Price Target Amid Encouraging Clinical and Regulatory Progress

TIPRANKS
·
Sep 10

Lead Customer Feedback Marks Progress in Qualification

GlobeNewswire
·
Sep 10

Candel Therapeutics Highlights Progress of Lead Oncology Candidate

TIPRANKS
·
Sep 10

J.Jill Maintained at Hold as Operational Progress Offsets Concerns Over Sustainability and Limited Profit Upside

TIPRANKS
·
Sep 10

Opus Genetics Reach 52-Week High on Clinical Trial, FDA Progress

Dow Jones
·
Sep 10

Boston Scientific’s RESPI Study Signals Progress in Wearable Breathing Monitoring

TIPRANKS
·
Sep 10